这篇文章不错，转发给_老虎社区_美港股上老虎 - 老虎社区

这篇文章不错，转发给大家看

@新股小诸葛：一天8家公司招股，怎么排序？

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

1

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":153542860,"tweetId":"153542860","gmtCreate":1625038792350,"gmtModify":1625038792350,"author":{"id":3583532798201114,"idStr":"3583532798201114","authorId":3583532798201114,"authorIdStr":"3583532798201114","name":"君常乐","avatar":"https://static.tigerbbs.com/cbef19f5689ab8b2d69123cc0e0aef58","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n这篇文章不错，转发给大家看</body></html>","htmlText":"<html><head></head><body>\n这篇文章不错，转发给大家看</body></html>","text":"这篇文章不错，转发给大家看","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/153542860","repostId":153679134,"repostType":1,"repost":{"magic":2,"id":153679134,"tweetId":"153679134","gmtCreate":1625022780000,"gmtModify":1625024884901,"author":{"id":3550637927571747,"idStr":"3550637927571747","authorId":3550637927571747,"authorIdStr":"3550637927571747","name":"新股小诸葛","avatar":"https://static.tigerbbs.com/7ba9f035f36c20133d5ae188299470fc","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":461,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"一天8家公司招股，怎么排序？","extraTitle":"","html":"<html><head></head><body><p><span>今天新股很多，小诸葛就简单说说，直接给答案：</span></p> <p><strong><span>1</span><span>.康圣环球：</span></strong><span>特检中血液检测第一股，业绩还可以，但是其实增速和盈利能力上来看，还没有表现出来，虽然有第一股之称，但是多多少少有些瑕疵。</span></p> <p><strong><span>2</span><span>.腾盛博药：</span></strong><span>只做最难的药，基本上把能用的资源都用了，也跟药明系合作了，也有国际药企</span><span>GSK</span><span>的创始人和高管。一手入场费</span><span>11237</span><span>港币，价格</span><span>21-22.25</span><span>港币，一手</span><span>500</span><span>股，对应按照目前的热度，预计参与人数</span><span>20-40</span><span>万左右，预计一手中签率</span><span>5%-10%</span><span>左右，预计</span><span>60-80</span><span>手可中一手，预计乙头可中</span><span>5-7</span><span>手左右。乙头</span><span>600</span><span>手，</span><span>592</span><span>万港币，</span><span>20</span><span>倍孖展需本金约</span><span>34</span><span>万港币</span><span>.</span></p> <p><span>本次招股基石基本吃完，</span><span>Invesco</span><span>、</span><span>UBS</span><span>、常春藤、</span><span>AIHC</span><span>、博裕、红杉等，按中间价计算，占比约</span><span>49%</span><span>。</span></p> <p><strong><span>3</span><span>.医脉通：</span></strong><span>自带互联网属性，波动比较大，现在市场比较热的是它，可能有人把它定位成下一个医渡科技，财务增速快，想象空间大，给到估值溢价也很正常。一手入场费</span><span>13737</span><span>港币，价格</span><span>24.1-27.2</span><span>港币，一手</span><span>500</span><span>股，对应按照目前的热度，预计参与人数</span><span>20-40</span><span>万左右，预计一手中签率</span><span>10%-15%</span><span>左右，预计</span><span>60-80</span><span>手可中一手，考虑到热票较多，且医脉通募资较多，预计乙头可中</span><span>8</span><span>手左右。乙头</span><span>400</span><span>手，</span><span>549</span><span>万港币，</span><span>20</span><span>倍孖展需本金约</span><span>27.5</span><span>万港币</span><span>。</span></p> <p><span>本次招股基石基本吃完，</span><span>FRM</span><span>、富达、</span><span>Tencent</span><span>、</span><span>GIC</span><span>、</span><span>Matthews</span><span>、</span><span>OrbiMed</span><span>、</span><span>Springhill</span><span>等，按中间价计算，占比约</span><span>42.3%</span><span>。</span></p> <p><strong><span>4.</span><span>环球新材：</span></strong><span>在珠光材料是隐形冠军，就是市值小了点，基本面还是比较稳定的。我也会参与</span></p> <p><span><strong><span>如果非要去配比的话，康圣：腾盛：医脉通：环球新材，小诸葛个人配比2：4：3：1。</span></strong></span></p> <p><strong><span>推荐阅读：</span></strong></p> <p><strong>1.康圣环球：中国血液检测龙头即将上市</strong></p> <p><span><strong>2.康诺亚生物招股，又是满基石？</strong></span></p> <p></p> <p><span><strong>你的每个转发、赞和在看，我都喜欢！</strong></span></p></body></html>","htmlText":"<html><head></head><body><p><span>今天新股很多，小诸葛就简单说说，直接给答案：</span></p> <p><strong><span>1</span><span>.康圣环球：</span></strong><span>特检中血液检测第一股，业绩还可以，但是其实增速和盈利能力上来看，还没有表现出来，虽然有第一股之称，但是多多少少有些瑕疵。</span></p> <p><strong><span>2</span><span>.腾盛博药：</span></strong><span>只做最难的药，基本上把能用的资源都用了，也跟药明系合作了，也有国际药企</span><span>GSK</span><span>的创始人和高管。一手入场费</span><span>11237</span><span>港币，价格</span><span>21-22.25</span><span>港币，一手</span><span>500</span><span>股，对应按照目前的热度，预计参与人数</span><span>20-40</span><span>万左右，预计一手中签率</span><span>5%-10%</span><span>左右，预计</span><span>60-80</span><span>手可中一手，预计乙头可中</span><span>5-7</span><span>手左右。乙头</span><span>600</span><span>手，</span><span>592</span><span>万港币，</span><span>20</span><span>倍孖展需本金约</span><span>34</span><span>万港币</span><span>.</span></p> <p><span>本次招股基石基本吃完，</span><span>Invesco</span><span>、</span><span>UBS</span><span>、常春藤、</span><span>AIHC</span><span>、博裕、红杉等，按中间价计算，占比约</span><span>49%</span><span>。</span></p> <p><strong><span>3</span><span>.医脉通：</span></strong><span>自带互联网属性，波动比较大，现在市场比较热的是它，可能有人把它定位成下一个医渡科技，财务增速快，想象空间大，给到估值溢价也很正常。一手入场费</span><span>13737</span><span>港币，价格</span><span>24.1-27.2</span><span>港币，一手</span><span>500</span><span>股，对应按照目前的热度，预计参与人数</span><span>20-40</span><span>万左右，预计一手中签率</span><span>10%-15%</span><span>左右，预计</span><span>60-80</span><span>手可中一手，考虑到热票较多，且医脉通募资较多，预计乙头可中</span><span>8</span><span>手左右。乙头</span><span>400</span><span>手，</span><span>549</span><span>万港币，</span><span>20</span><span>倍孖展需本金约</span><span>27.5</span><span>万港币</span><span>。</span></p> <p><span>本次招股基石基本吃完，</span><span>FRM</span><span>、富达、</span><span>Tencent</span><span>、</span><span>GIC</span><span>、</span><span>Matthews</span><span>、</span><span>OrbiMed</span><span>、</span><span>Springhill</span><span>等，按中间价计算，占比约</span><span>42.3%</span><span>。</span></p> <p><strong><span>4.</span><span>环球新材：</span></strong><span>在珠光材料是隐形冠军，就是市值小了点，基本面还是比较稳定的。我也会参与</span></p> <p><span><strong><span>如果非要去配比的话，康圣：腾盛：医脉通：环球新材，小诸葛个人配比2：4：3：1。</span></strong></span></p> <p><strong><span>推荐阅读：</span></strong></p> <p><strong>1.康圣环球：中国血液检测龙头即将上市</strong></p> <p><span><strong>2.康诺亚生物招股，又是满基石？</strong></span></p> <p></p> <p><span><strong>你的每个转发、赞和在看，我都喜欢！</strong></span></p></body></html>","text":"今天新股很多，小诸葛就简单说说，直接给答案： 1.康圣环球：特检中血液检测第一股，业绩还可以，但是其实增速和盈利能力上来看，还没有表现出来，虽然有第一股之称，但是多多少少有些瑕疵。 2.腾盛博药：只做最难的药，基本上把能用的资源都用了，也跟药明系合作了，也有国际药企GSK的创始人和高管。一手入场费11237港币，价格21-22.25港币，一手500股，对应按照目前的热度，预计参与人数20-40万左右，预计一手中签率5%-10%左右，预计60-80手可中一手，预计乙头可中5-7手左右。乙头600手，592万港币，20倍孖展需本金约34万港币. 本次招股基石基本吃完，Invesco、UBS、常春藤、AIHC、博裕、红杉等，按中间价计算，占比约49%。 3.医脉通：自带互联网属性，波动比较大，现在市场比较热的是它，可能有人把它定位成下一个医渡科技，财务增速快，想象空间大，给到估值溢价也很正常。一手入场费13737港币，价格24.1-27.2港币，一手500股，对应按照目前的热度，预计参与人数20-40万左右，预计一手中签率10%-15%左右，预计60-80手可中一手，考虑到热票较多，且医脉通募资较多，预计乙头可中8手左右。乙头400手，549万港币，20倍孖展需本金约27.5万港币。 本次招股基石基本吃完，FRM、富达、Tencent、GIC、Matthews、OrbiMed、Springhill等，按中间价计算，占比约42.3%。 4.环球新材：在珠光材料是隐形冠军，就是市值小了点，基本面还是比较稳定的。我也会参与 如果非要去配比的话，康圣：腾盛：医脉通：环球新材，小诸葛个人配比2：4：3：1。 推荐阅读： 1.康圣环球：中国血液检测龙头即将上市 2.康诺亚生物招股，又是满基石？ 你的每个转发、赞和在看，我都喜欢！","highlighted":1,"essential":1,"paper":2,"link":"https://laohu8.com/post/153679134","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["02162","02137","06616","02192","09960"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1257,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":2017,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":25,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/153542860"}